PBXIP1 and neoplasm: A novel small molecule named TXX-1-10 derived from rimonabant, an antagonist for the cannabinoid receptor CB1 was identified to reduce HPIP expression together with its downstream targets and inhibit tumor growth and metastasis with great efficacy than rimonabant.